Registered Nurse in Scituate, MA Accepting Medicare

7 Registered Nurse nurses found. Showing 1 - 7

Ms. Ann Lorraine Barry, R.N. Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 54 Kings Way, Scituate, MA 02066 Phone: 781-470-9058

Judith Waterman Kamara, LCSW Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 109 Old Oaken Bucket Rd, Scituate, MA 02066 Phone: 781-228-0980

Deana Ashley Kelly, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 257 Gannett Rd, Scituate, MA 02066 Phone: 617-529-0789

Ms. Jeanne Travis, Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 58 Marys Ln, Scituate, MA 02066 Phone: 781-724-4737

Cere Mcveigh, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 New Driftway Ste 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

Tracey Diane Siciliano, R.N Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 39 -a Beaver Dam Rd., Scituate, MA 02066 Phone: 781-545-7604

Ms. Mary Ellen Logan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 109 Elm St, Scituate, MA 02066 Phone: 617-645-3984

News Archive

GE Healthcare concentrates on healthymagination to help patients live longer and healthier

Miniaturized ultrasound. Navigation during interventional procedures. Innovations in sound wave imaging. At RSNA 2009, GE Healthcare is finding better ways to see more. And using that information to do more.

Study finds cervicovaginal microbiota differs in women destined to have preterm birth

​In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that cervicovaginal (CV) microbiota differs in the late second and early third trimester in women destined to have a preterm birth.

CTI to market ETView Medical's VivaSight products in US

ETView Medical Ltd. announced today that it has entered into an exclusive distribution agreement with Clinical Technologies, Inc.

Northstar Healthcare second-quarter net patient service revenue decreases to $4.4 million

Northstar Healthcare Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

Read more Medical News

› Verified 3 days ago